ARK Investment Management LLC 13D and 13G filings for Recursion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 12:21 pm Purchase | 2024-01-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX | ARK Investment Management LLC | 23,076,052 11.080% | 2,421,765 (+11.73%) | Filing |
| 2024-01-29 4:00 pm Purchase | 2023-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX | ARK Investment Management LLC | 20,654,287 9.920% | 20,654,287 (New Position) | Filing |